Risk for Severe COVID-19 Low in Patients With Psoriatic Disease
Researchers reported on the severity of COVID-19 outcomes in patients with psoriatic disease, using data from the WARCOV study.
Researchers reported on the severity of COVID-19 outcomes in patients with psoriatic disease, using data from the WARCOV study.
Masks are important for preventing COVID-19 incidence in kindergarten through grade 12 (K-12) school settings.
Pfizer Inc announced Tuesday that it has launched a phase 2/3 clinical trial of its COVID-19 antiviral pill known as Paxlovid in children ages 6 to 17 years.
In a cohort of K-12 schools, secondary transmission of severe acute respiratory syndrome coronavirus 2 was low and was reduced by universal masking.
During the 2021-2022 season, influenza vaccination did not reduce the risk for outpatient medically attended illness with influenza A(H3N2) viruses that have predominated this season.
Mask mandates for airplanes, trains, and transit hubs that were set to expire next week will be extended to April 18.
For individuals hospitalized with COVID-19, continuing treatment with dexamethasone at discharge is not associated with a reduction in 14-day all-cause readmission or mortality.
The incidence of severe COVID-19 infections was lower than expected among dialysis patients from the beginning of vaccine rollout.
Patients who repeatedly tested negative but had signs/symptoms of COVID-19 had similar seroprevalence as RT-PCR-confirmed cases
Improvements seen in symptoms of fatigue, breathing difficulties, 6-minute walk test with EECP treatment